Literature DB >> 36264889

Acceptance and hesitancy of COVID-19 vaccine among Nepalese population: A cross-sectional study.

Suresh Dahal1, Srishti Pokhrel1, Subash Mehta1, Supriya Karki1, Harish Chandra Bist1, Dikesh Kumar Sahu1, Nimesh Lageju2, Sagar Panthi2, Durga Neupane2, Ashish Shrestha1, Tarakant Bhagat1, Santosh Kumari Agrawal1, Ujwal Gautam1.   

Abstract

INTRODUCTION: COVID-19 is an emerging infectious disease with a high transmission rate and substantial deaths. Various vaccines have been developed to combat it. This study is aimed to assess COVID-19 vaccine acceptance and hesitancy among the Nepalese population through a web-based survey.
MATERIALS AND METHODS: This is a web-based cross-sectional descriptive study of Nepalese people 18 years and above from different regions of Nepal who use social media (Facebook, Twitter, Reddit) as well as instant messaging applications (Messenger, Viber, WhatsApp). The duration of the study was 3 months from 1st June 2021 to 31st August 2021. The sampling technique used was self-selected non-probability sampling. A validated questionnaire had been taken to record the data.
RESULTS: A total of 307 participants were included in the study. About three-fourths of participants 231 (75.2%) had not been vaccinated while 76 (24.8%) had been vaccinated with COVID -19 vaccine. Out of 231 non-vaccinated participants, most of participants 213 (92.2%) had shown acceptance of the COVID-19 vaccine. More than two-thirds of participants believed that the vaccine would protect them, their family members, and the community from having COVID-19 in the future. Very few participants 18 (7.2%) were hesitant to receive the vaccine against COVID-19. About two-thirds of participants were being afraid of adverse effects of the COVID-19 vaccine while more than half of participants hesitated due to lack of enough information regarding COVID-19 vaccine.
CONCLUSION: This study can aid in the planning of vaccination campaigns and the direction of future public health efforts aimed at increasing COVID-19 vaccine uptake.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36264889      PMCID: PMC9584529          DOI: 10.1371/journal.pone.0275922

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  30 in total

Review 1.  Ten considerations for effectively managing the COVID-19 transition.

Authors:  Katrine Bach Habersaat; Cornelia Betsch; Margie Danchin; Cass R Sunstein; Robert Böhm; Armin Falk; Noel T Brewer; Saad B Omer; Martha Scherzer; Sunita Sah; Edward F Fischer; Andrea E Scheel; Daisy Fancourt; Shinobu Kitayama; Eve Dubé; Julie Leask; Mohan Dutta; Noni E MacDonald; Anna Temkina; Andreas Lieberoth; Mark Jackson; Stephan Lewandowsky; Holly Seale; Nils Fietje; Philipp Schmid; Michele Gelfand; Lars Korn; Sarah Eitze; Lisa Felgendreff; Philipp Sprengholz; Cristiana Salvi; Robb Butler
Journal:  Nat Hum Behav       Date:  2020-06-24

2.  Attitudes and Perceptions Towards Coronavirus Disease 2019 (COVID-19) Vaccine Acceptance Among Recovered African American Patients.

Authors:  Titilope Olanipekun; Temidayo Abe; Valery Effoe; Suaka Kagbo-Kue; Iloabueke Chineke; Chinedu Ivonye; Nicolas Bakinde
Journal:  J Gen Intern Med       Date:  2021-04-26       Impact factor: 5.128

3.  Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine.

Authors:  Maria Cordina; Mary A Lauri; Josef Lauri
Journal:  Pharm Pract (Granada)       Date:  2021-03-22

4.  Perception, Preventive Practice, and Attitude Towards Vaccine Against COVID-19 Among Health Care Professionals in Bangladesh.

Authors:  Morshed Nasir; Md Anisuz Zaman; Touhidul Karim Majumder; Faruque Ahmed; Rumana Nazneen; Eliza Omar; Rawshan Ara Perveen; Nadia Farha; Tahmina Zahan; Mir Jakib Hossain; Sultana Parvin; Moshfiqur Rahman Chowdhury; Hasina Begum
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

5.  Overview: special focus vaccine acceptance.

Authors:  Kristen A Feemster
Journal:  Hum Vaccin Immunother       Date:  2013-08-01       Impact factor: 3.452

Review 6.  The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world.

Authors:  Hannah R Sharpe; Ciaran Gilbride; Elizabeth Allen; Sandra Belij-Rammerstorfer; Cameron Bissett; Katie Ewer; Teresa Lambe
Journal:  Immunology       Date:  2020-07       Impact factor: 7.397

7.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19

8.  Vaccine hesitancy: the next challenge in the fight against COVID-19.

Authors:  Amiel A Dror; Netanel Eisenbach; Shahar Taiber; Nicole G Morozov; Matti Mizrachi; Asaf Zigron; Samer Srouji; Eyal Sela
Journal:  Eur J Epidemiol       Date:  2020-08-12       Impact factor: 8.082

9.  COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.

Authors:  Julio S Solís Arce; Shana S Warren; Niccolò F Meriggi; Alexandra Scacco; Nina McMurry; Maarten Voors; Georgiy Syunyaev; Amyn Abdul Malik; Samya Aboutajdine; Opeyemi Adeojo; Deborah Anigo; Alex Armand; Saher Asad; Martin Atyera; Britta Augsburg; Manisha Awasthi; Gloria Eden Ayesiga; Antonella Bancalari; Martina Björkman Nyqvist; Ekaterina Borisova; Constantin Manuel Bosancianu; Magarita Rosa Cabra García; Ali Cheema; Elliott Collins; Filippo Cuccaro; Ahsan Zia Farooqi; Tatheer Fatima; Mattia Fracchia; Mery Len Galindo Soria; Andrea Guariso; Ali Hasanain; Sofía Jaramillo; Sellu Kallon; Anthony Kamwesigye; Arjun Kharel; Sarah Kreps; Madison Levine; Rebecca Littman; Mohammad Malik; Gisele Manirabaruta; Jean Léodomir Habarimana Mfura; Fatoma Momoh; Alberto Mucauque; Imamo Mussa; Jean Aime Nsabimana; Isaac Obara; María Juliana Otálora; Béchir Wendemi Ouédraogo; Touba Bakary Pare; Melina R Platas; Laura Polanco; Javaeria Ashraf Qureshi; Mariam Raheem; Vasudha Ramakrishna; Ismail Rendrá; Taimur Shah; Sarene Eyla Shaked; Jacob N Shapiro; Jakob Svensson; Ahsan Tariq; Achille Mignondo Tchibozo; Hamid Ali Tiwana; Bhartendu Trivedi; Corey Vernot; Pedro C Vicente; Laurin B Weissinger; Basit Zafar; Baobao Zhang; Dean Karlan; Michael Callen; Matthieu Teachout; Macartan Humphreys; Ahmed Mushfiq Mobarak; Saad B Omer
Journal:  Nat Med       Date:  2021-07-16       Impact factor: 87.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.